These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24446303)

  • 21. Chemical proteomics and its application to drug discovery.
    Jeffery DA; Bogyo M
    Drug Discov Today; 2004 Jan; 9(2 Suppl):S19-26. PubMed ID: 23573640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How has the genomics era impacted schistosomiasis drug discovery?
    Oliveira G; Pierce RJ
    Future Med Chem; 2015; 7(6):685-7. PubMed ID: 25996060
    [No Abstract]   [Full Text] [Related]  

  • 23. Structure-based approaches to antibiotic drug discovery.
    Nicola G; Abagyan R
    Curr Protoc Microbiol; 2009 Feb; Chapter 17():Unit17.2. PubMed ID: 19235149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of a Drug Discovery Method Targeted to Stromal Tissue].
    Kamada H
    Yakugaku Zasshi; 2016; 136(3):435-41. PubMed ID: 26935083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From DNA binding to metabolic control: integration of -omics data reveals drug targets for prostate cancer.
    Gao H; Dahlman-Wright K
    EMBO J; 2011 Jul; 30(13):2516-7. PubMed ID: 21731047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Network approaches to drug discovery.
    Chandra N; Padiadpu J
    Expert Opin Drug Discov; 2013 Jan; 8(1):7-20. PubMed ID: 23140510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomics and drug discovery.
    Lundstrom K
    Future Med Chem; 2011 Nov; 3(15):1855-8. PubMed ID: 22023028
    [No Abstract]   [Full Text] [Related]  

  • 28. Leveraging Genomic Factors to Improve Benefit-Risk.
    Schuck RN; Charlab R; Blumenthal GM
    Clin Transl Sci; 2017 Mar; 10(2):78-83. PubMed ID: 28160443
    [No Abstract]   [Full Text] [Related]  

  • 29. [Chemical proteomics and discovery of drug targets].
    Yang HQ; Li XJ
    Yao Xue Xue Bao; 2011 Aug; 46(8):877-82. PubMed ID: 22007509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical proteomics in drug discovery.
    Drewes G
    Methods Mol Biol; 2012; 803():15-21. PubMed ID: 22065215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic and proteomic strategies to identify novel targets potentially involved in learning and memory.
    Benoit CE; Rowe WB; Menard C; Sarret P; Quirion R
    Trends Pharmacol Sci; 2011 Jan; 32(1):43-52. PubMed ID: 21129790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical-genomic profiling: systematic analysis of the cellular targets of bioactive molecules.
    Andrusiak K; Piotrowski JS; Boone C
    Bioorg Med Chem; 2012 Mar; 20(6):1952-60. PubMed ID: 22261022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recent progress in the study of fungal virulence factors and identification of new targets of anti-fungal drug using proteomic and transcriptomic analysis].
    Toyotome T; Watanabe A; Kamei K
    Nihon Rinsho; 2008 Dec; 66(12):2255-60. PubMed ID: 19069088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving lead generation success through integrated methods: transcending 'drug discovery by numbers'.
    Campbell JB
    IDrugs; 2010 Dec; 13(12):874-9. PubMed ID: 21154146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leveraging big data to transform target selection and drug discovery.
    Chen B; Butte AJ
    Clin Pharmacol Ther; 2016 Mar; 99(3):285-97. PubMed ID: 26659699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subtractive genomics approach to identify putative drug targets and identification of drug-like molecules for beta subunit of DNA polymerase III in Streptococcus species.
    Georrge JJ; Umrania VV
    Appl Biochem Biotechnol; 2012 Jul; 167(5):1377-95. PubMed ID: 22415782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomics and proteomics in process development: opportunities and challenges.
    Gupta P; Lee KH
    Trends Biotechnol; 2007 Jul; 25(7):324-30. PubMed ID: 17475353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A network-heuristic approach to improve the impact of genomic data on drug discovery.
    Trister AD; Huang ES
    Clin Pharmacol Ther; 2013 Apr; 93(4):295-7. PubMed ID: 23511782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomics in Drug Development: The Dawn of a New Era?
    Frantzi M; Latosinska A; Mischak H
    Proteomics Clin Appl; 2019 Mar; 13(2):e1800087. PubMed ID: 30724014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Challenge to the Development of Molecular Targeted Therapy against a Novel Target Candidate Identified by Antibody Proteomics Technology].
    Nagano K
    Yakugaku Zasshi; 2016; 136(2):145-9. PubMed ID: 26831784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.